z-logo
Premium
Left atrial expansion index predicts all‐cause mortality and heart failure admissions in dyspnoea
Author(s) -
Hsiao ShihHung,
Chiou KuanRau
Publication year - 2013
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1093/eurjhf/hft087
Subject(s) - medicine , heart failure , cardiology , index (typography) , world wide web , computer science
Aims The power of left atrial (LA) parameters for predicting adverse events in relatively low‐risk groups is not fully understood. This study investigated whether the LA expansion index predicts heart failure (HF) and all‐cause mortality in subjects with dyspnoea. Methods and results Echocardiography was performed to identify causes of dypnoea in 1735 patients. The LA expansion index was calculated as (Vol max – Vol min ) × 100%/Vol min , where Vol max was defined as the maximal LA volume and Vol min was defined as the minimal LA volume. The endpoints were 2‐year frequencies of HF hospitalization and all‐cause mortality. Over a median follow‐up of 2.7 years, 91 participants reached endpoints. Rates of adverse events were exponentially proportional to the LA expansion index. For predicting adverse events, the LA expansion index was better than the maximal indexed LA volume and tissue Doppler parameters. Hospitalization for HF was independently associated with age, LVEF, pulmonary artery systolic pressure, LA expansion index, and history of prior HF. All‐cause mortality was associated with age, pulmonary artery systolic pressure, and LA expansion index. Compared with the highest quartile of the LA expansion index, the lowest quartile had a 3.1‐fold higher hazard of HF events and a 17.8‐fold higher hazard of all‐cause mortality. Conclusions The LA expansion index predicts adverse events in patients with dyspnoea. The prognostic power of the index exceeds that of other well‐established echocardiographic parameters such as E/e' and maximal indexed LA volume. Trial registration NCT01171040.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here